Clinical characteristics and outcomes of paediatric chronic non-bacterial osteomyelitis: a retrospective cohort study with focus on zoledronic acid. [PDF]
Herman Y +9 more
europepmc +1 more source
Pseudogout attack following zoledronic acid treatment in primary hyperparathyroidism. [PDF]
Emur Gunay Y, Gunay M.
europepmc +1 more source
Zoledronic Acid-Induced Orbital Inflammation: A Diagnostic Challenge. [PDF]
Nasrini T, Bacon A, Umesh S.
europepmc +1 more source
Zoledronic acid produces analgesia by inhibiting the transient receptor potential vanilloid 1 (TRPV1) channel. [PDF]
Carvajal-Zamorano K +15 more
europepmc +1 more source
Efficacy and safety of zoledronic acid versus denosumab in the treatment of primary osteoporosis: a single-center retrospective cohort study. [PDF]
Li X +8 more
europepmc +1 more source
Papulovesicular eruption after administration of zoledronic acid: A rare cutaneous manifestation of an acute phase reaction. [PDF]
Lian SB, Liang MW, Heng YK.
europepmc +1 more source
Zoledronic acid in the treatment of severe scoliosis associated with neurofibromatosis type 1 (NF1): a case report. [PDF]
Huang C, Wang S, Yue L, Sun H.
europepmc +1 more source
Exacerbation of myasthenia gravis after zoledronic acid and denosumab: a novel clinical observation with therapeutic implications. [PDF]
Canneva S +5 more
europepmc +1 more source
Fanconi syndrome induced by zoledronic acid: Two case reports. [PDF]
Chen Y +5 more
europepmc +1 more source
Breast-cancer Adjuvant Therapy With Zoledronic Acid
BACKGROUND: Data suggest that the adjuvant use of bisphosphonates reduces rates of recurrence and death in patients with early-stage breast cancer. We conducted a study to determine whether treatment with zoledronic acid, in addition to standard adjuvant
Peterson, Jennifer +18 more
core

